C WorldWide tops external AM ranking in Sweden

Jonathan Boyd
clock • 2 min read

C WorldWide Asset Management, formerly Carnegie Asset Management, has topped the latest survey by KANTAR SIFO Prospera of Swedish institutional investors and their views of external asset managers.

In the methodology, C WorldWide scored 4/5 based on some 136 interviews done in April and May 2018, which covered boutiques, to major banks and international providers.

Handelsbanken (3.95), Carnegie Fonder (3.88), Cliens (3.88) and Öhman (3.82) make up the top five positions according to the survey.

The survey asked for institutions’ views of asset managers skills, results, product quality and administration among other factors.

Ralf Larsson, head of Swedish Clients at C WorldWide Asset Management, said: “We’re very happy and proud over this award.  The biggest and most important institutional investors in Sweden have had their say and we can only humbly conclude that we seem to be doing a good job. We’re also pleased that the award does not focus on a single variable but takes a 360 degree view.  This is a fantastic proof of the quality of our offering.”

C WorldWide Asset Management also topped the list of the institutions’ willingness to recommend asset managers to others, with an average score of 4.25, noted Larsson.

The full name of the group reflects its Danish roots. The survey reviewed  C WorldWide Asset Management Fondsmaeglerselskab A/S Danmark Filial i Sverige; the group manages some $19.7bn (€17bn) globally. For a number of years the organisation shared the same name with  Carnegie Investment Bank AB of Sweden, but the use of similar names led the Danish business to make the switch to a new name, however its strategies and ongoing investment philosophy since 1986 remain unchanged.

Investors can also access a suite of strategies that are distributed in a Luxembourg Ucits and non-Ucits format, including global equities, global equities ethical, stable equities, long/short global, long/short Europe, Asia, emerging markets, Nordic, medical, medical small & mid cap and biotechnology.